rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Merck Sharp Dohme Pharmaceuticals

Rediff.com  »  News  »   Merck Sharp Dohme Pharmaceuticals

  News for Merck Sharp Dohme Pharmaceuticals

  • Business

Drug patent row: HC to hear US co on Apr 12

Delhi High Court on Wednesday posted for April 12 an appeal filed by US pharmaceuticals major Merck Sharp and Dohme against the single judge bench order refusing to restrain Indian firm Glenmark......

Patent row: HC refuses interim relief to Merck

The Delhi High Court on Friday refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme which sought a restraint on Indian firm Glenmark Pharmaceuticals on......

Merck moves HC against Glenmark

In yet another legal battle between a multinational company and domestic drug manufacturing firms, Merck Sharp and Dohme has moved the Delhi High Court against Mumbai-based Glenmark......

Merck to roll out money-spinning drugs soon

Merck Sharp & Dohme Pharmaceuticals, wholly owned subsidiary of US drug major Merck and Co, is all set to introduce three of its money-spinning drugs - Cosopt, Invanz and Pneuvax -worth over $650......

Merck in talks with GVK, Biocon for R&D tie-up

Merck Sharp & Dohme India, a subsidiary of the US-based Merck & Co, is in talks with Biocon and GVK Pharmaceuticals, among others, to expand its research and drug development activities.The company......
  Web results for Merck Sharp Dohme Pharmaceuticals
Fortis gets BMJ award for 'Antibiotic Review Programme & Antibiotic Restriction Policy'

Fortis Healthcare, a Rs.4,700 crore healthcare company, announced that Fortis Mulund, one of its major hospitals in Mumbai has been conferred the... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=84298&sid=2
MSD Presents First Phase 3 Data in Japanese Patients for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes

Comments - Vienna, AustriaMSD, known as Merck & Co., Inc. (NYSE:MRK) in the United States and Canada, has announced the presentation of the first... ...

http://www.andhranews.net/Intl/2014/MSD-Presents-First-Phase-3-Data-2644.htm
Global Diclofenac Industry Report 2014

From the Wires Sep. 12, 2014 01:34 PM DUBLIN , Sept. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the... ...

http://in.sys-con.com/node/3183583
Vree Health Launches EngageAdvantage(TM) to Help Improve Patient Outcomes

WHITEHOUSE STATION, N.J., Sept. 10, 2014 /PRNewswire/ -- Vree Health, a company that combines technology with direct personal interaction to... ...

http://www.itnewsonline.com/prnewswire/Vree-Health-Launches-EngageAdvantage(TM)-to-Help-Improve-Patient-Outcomes/341753
Allergic Rhinitis Drugs Market Forecast 2014-2024

/PRNewswire/ -- Allergic rhinitis drugs - new study showing you trends, R&D progress, and predicted revenues Where is the allergic... ...

http://in.advfn.com/p.php?pid=nmona&article=63333790

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z